CLEANSCRIPT Trademark

Trademark Overview

On Friday, October 21, 2022, a trademark application was filed for CLEANSCRIPT with the United States Patent and Trademark Office. The USPTO has given the CLEANSCRIPT trademark a serial number of 97642700. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2024. This trademark is owned by TriLink BioTechnologies, LLC. The CLEANSCRIPT trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Providing custom manufacture of mRNA and long RNA for others, namely, custom synthesis and combinations of mRNA and long RNA molecules
cleanscript

General Information

Serial Number97642700
Word MarkCLEANSCRIPT
Filing DateFriday, October 21, 2022
Status700 - REGISTERED
Status DateTuesday, April 2, 2024
Registration Number7348566
Registration DateTuesday, April 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements

Goods and ServicesProviding custom manufacture of mRNA and long RNA for others, namely, custom synthesis and combinations of mRNA and long RNA molecules
Pseudo MarkCLEAN SCRIPT

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, November 6, 2022
Primary Code040
First Use Anywhere DateTuesday, October 31, 2023
First Use In Commerce DateTuesday, October 31, 2023

Trademark Owner History

Party NameTriLink BioTechnologies, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSAN DIEGO, CA 92121
Party NameTriLink BioTechnologies, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameTriLink BioTechnologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, October 25, 2022NEW APPLICATION ENTERED
Sunday, November 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, July 2, 2023ASSIGNED TO EXAMINER
Monday, July 10, 2023NON-FINAL ACTION WRITTEN
Monday, July 10, 2023NON-FINAL ACTION E-MAILED
Monday, July 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 5, 2024TEAS STATEMENT OF USE RECEIVED
Monday, February 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 5, 2024SOU EXTENSION 1 FILED
Monday, February 5, 2024USE AMENDMENT FILED
Wednesday, February 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 21, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 29, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2024REGISTERED-PRINCIPAL REGISTER
Friday, September 20, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 20, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

cleanscript mrna long custom combinations molecules synthesis others providing manufacture namely